CoChat

Fighting Cardiac Fibrosis with CAR T Cells

Friedman, Scott L. · 2022 · New England Journal of Medicine

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Autologous chimeric antigen receptor T cells, which are engineered to bind and kill cells that express a specific antigen, are effective in the treatment of certain cancers. A recent study involving a mouse model shows that CAR T cells can be generated in vivo and may reduce fibrosis after myocardial injury.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmcibr2201182

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Friedman, S. L.
Affiliations
Icahn School of Medicine at Mount Sinai (US)
Corresponding author
Friedman, Scott L.
Venue
New England Journal of Medicine
Published
2022-04-21
Volume
386
Issue
16
Pages
1576-1578
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4224285902
Cited by
28
References
7
Citations by year
2026: 4 · 2025: 10 · 2024: 4 · 2023: 4 · 2022: 6
FWCI
4.21
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
myocardial fibrosis, chimeric antigen receptor T cells, CAR T-cell therapy, myocardial injury, mouse model
MeSH terms
Receptors, Chimeric Antigen, Fibrosis, Heart Diseases, Humans, T-Lymphocytes, Immunotherapy, Adoptive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.